Recent Updates
Recently added Catalysts

DG3173

Phase 1

Healthy | Small molecule | Other |Evotec SE|Trials Updated: Aug 15, 2014

DG3173 development status

Highest phase Phase 1
Registered trials 1 across 1 sponsor since Aug 2014

Success Probability

Subscribe to view

Market & Valuation

Subscribe to view

Trial Design

RandomizedDouble-BlindPLACEBO_CONTROLLEDBiomarker
Total Trials1
Total Enrollment72

FDA Designations

No designations recorded

DG3173 clinical trials

DG3173 · 1 trial · 1 indication

Phase 1 1
NCT02217488Single Ascending Dose Tolerability Study of DG3173Healthy
COMPLETED72 Analytics
PHASE1COMPLETED
Single Ascending Dose Tolerability Study of DG3173
Healthy
NCT0221748872
Unlock trial analytics

Study Endpoints

Primary Endpoints

Number of serious adverse events or withdrawals due to adverse events
One week
Unlock Study Endpoints

Study Design & Arms

AllocationRANDOMIZED
MaskingQUADRUPLE
ModelSINGLE_GROUP
PurposeTREATMENT

Treatment Arms

ArmTypeDescription
DG3173EXPERIMENTAL -
VehiclePLACEBO_COMPARATOR -

Interventions

NameTypeDescription
DG3173DRUG -
PlaceboDRUG -
Unlock Study Design Details

Eligibility Criteria

Age Range18 Years to 45 Years
SexMALE
Healthy VolunteersYes

Inclusion Criteria: * Ethnic origine: Caucasian * Weight: 55-95 kg * BMI: 19-29 kg/qm * Medical history without clinically relevant pathologies * Physical examination parameters and lung function without signs of clinically relevant pathologies * Electrocardiogram recording without signs of clinica...

Unlock Eligibility Criteria

Explore more on BiopharmaWatch

Evotec SE (EVO)Pipeline, catalysts, financials, insiders and newsBiotech disease mapWho is developing what in each indication, and how crowded it isFDA calendarUpcoming PDUFA dates, AdComs and approval oddsPDUFA calendarEvery scheduled FDA decision date, month by monthHistorical FDA calendarPast decisions and how the stock moved on eachCatalyst SyncUpcoming readouts and decisions, screened by runway and phaseBiotech stock screenerFilter by clinical phase, cash runway and market capDrugs A to ZEvery drug page starting with DCompanies A to ZEvery biotech and pharma company we track